CYTO - Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript
2024-04-10 11:18:10 ET
Altamira Therapeutics Ltd. (CYTO)
Q4 2023 Earnings Conference Call
April 10, 2024, 08:30 AM ET
Company Participants
Thomas Meyer - Founder, Chairman & Chief Executive Officer
Covadonga Pañeda - Chief Operating Officer
Presentation
Operator
Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call.
On today's call are Thomas Meyer, Altamira's Founder, Chairman and the Chief Executive Officer, and Covadonga Pañeda, Altamira's Chief Operating Officer.
Earlier today, Altamira issued a news release with full year 2023 financial results as well as a comprehensive business update. The release is available on the company's website at www.altamiratherapeutics.com and has been filed with the SEC.
During today's call, the company will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements that address future operating, financial or business performance or its strategies or expectations. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, development and business decisions to differ materially from those contemplated by these statements....
Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript